Suppr超能文献

与欧洲国家中老年人社区居住者药物滥用和药物相关问题高风险相关的因素:一项纵向研究。

Factors associated with polypharmacy and the high risk of medication-related problems among older community-dwelling adults in European countries: a longitudinal study.

机构信息

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P.O, . Box 2040, 3000 CA, Rotterdam, The Netherlands.

Department of Social Medicine and Epidemiology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

出版信息

BMC Geriatr. 2022 Nov 7;22(1):841. doi: 10.1186/s12877-022-03536-z.

Abstract

BACKGROUND

Polypharmacy can be defined as using five or more medications simultaneously. "Medication-related problems", an extension of polypharmacy, includes inappropriate prescribing, poor adherence, overdosage, underdosage, inappropriate drug selection, inadequate monitoring, adverse drug effects, and drug interactions. Polypharmacy and the high risk of medication-related problems among older people are associated with adverse health consequences due to drug-drug interactions, drug-disease interactions, and adverse drug effects. This study aims to assess the factors associated with polypharmacy and the high risk of medication-related problems among community-dwelling older people in the Netherlands, Greece, Croatia, Spain, United Kingdom.

METHOD

This longitudinal study used baseline and follow-up data from 1791 participants of the Urban Health Center European project. Polypharmacy and the risk of medication-related problems were evaluated at baseline and follow-up using the Medication Risk Questionnaire. We studied factors in the domains (a) sociodemographic characteristics, (b) lifestyle and nutrition, and (c) health and health care use. Hierarchical logistic regression analyses were used to examine the factors associated with polypharmacy and the high risk of medication-related problems.

RESULTS

Mean age was 79.6 years (SD ± 5.6 years); 60.8% were women; 45.2% had polypharmacy, and 41.8% had a high risk of medication-related problems. Women participants had lower odds of polypharmacy (OR = 0.55;95%CI:0.42-0.72) and a high risk of medication-related problems (OR = 0.50; 95%CI:0.39-0.65). Participants with a migration background (OR = 1.67;95%CI:1.08-2.59), overweight (OR = 1.37; 95%CI:1.04-1.79) and obesity (OR = 1.78;95%CI:1.26-2.51) compared to 'normal weight', with lower physical HRQoL (OR = 0.96, 95%CI:0.95-0.98), multi-morbidity (OR = 3.73, 95%CI:2.18-6.37), frailty (OR = 1.69, 95%CI:1.24-2.30), visited outpatient services (OR = 1.77, 95%CI: 1.09-2.88) had higher odds of polypharmacy. The associations with the high risk of medication-related problems were similar.

CONCLUSIONS

Multiple factors in demography, lifestyle, nutrition, and health care use are associated with polypharmacy and the high risk of medication-related problems. Polypharmacy is a single element that may reflect the number of medications taken. The broader content of medication-related problems should be considered to assess the context of medication use among older people comprehensively. These provide starting points to improve interventions to reduce polypharmacy and high risk of medication-related problems. In the meantime, health professionals can apply these insights to identify subgroups of patients at a high risk of polypharmacy and medication-related problems.

TRIAL REGISTRATION

The intervention of the UHCE project was registered in the ISRCTN registry as ISRCTN52788952. The date of registration is 13/03/2017.

摘要

背景

同时使用五种或以上药物可被定义为多重用药。“药物相关问题”是对多重用药的扩展,包括不适当的处方、用药依从性差、用药过量、用药不足、药物选择不当、监测不足、药物不良反应和药物相互作用。老年人多重用药和高药物相关问题风险与药物-药物相互作用、药物-疾病相互作用和药物不良反应导致的不良健康后果有关。本研究旨在评估荷兰、希腊、克罗地亚、西班牙和英国社区居住的老年人中与多重用药和高药物相关问题风险相关的因素。

方法

本纵向研究使用了“城市健康中心欧洲项目”的 1791 名参与者的基线和随访数据。使用药物风险问卷在基线和随访时评估多重用药和高药物相关问题风险。我们研究了(a)社会人口学特征、(b)生活方式和营养、(c)健康和医疗保健使用领域的因素。使用分层逻辑回归分析来检验与多重用药和高药物相关问题风险相关的因素。

结果

平均年龄为 79.6 岁(标准差±5.6 岁);60.8%为女性;45.2%有多重用药,41.8%有高药物相关问题风险。女性参与者发生多重用药的可能性较低(比值比(OR)=0.55;95%置信区间(CI):0.42-0.72),发生高药物相关问题风险的可能性也较低(OR=0.50;95%CI:0.39-0.65)。与“正常体重”相比,有移民背景(OR=1.67;95%CI:1.08-2.59)、超重(OR=1.37;95%CI:1.04-1.79)和肥胖(OR=1.78;95%CI:1.26-2.51)的参与者、身体健康相关生活质量较低(OR=0.96;95%CI:0.95-0.98)、患有多种疾病(OR=3.73;95%CI:2.18-6.37)、衰弱(OR=1.69;95%CI:1.24-2.30)、接受门诊服务(OR=1.77;95%CI:1.09-2.88)的参与者发生多重用药的可能性更高。与高药物相关问题风险的关联相似。

结论

人口统计学、生活方式、营养和医疗保健使用方面的多种因素与多重用药和高药物相关问题风险相关。多重用药是反映服用药物数量的单一因素。应考虑更广泛的药物相关问题内容,以全面评估老年人的药物使用情况。这些为改善干预措施以减少多重用药和高药物相关问题风险提供了起点。同时,卫生专业人员可以利用这些见解来识别高风险的多重用药和药物相关问题的患者亚组。

试验注册

UHCE 项目的干预措施已在 ISRCTN 注册处作为 ISRCTN52788952 进行注册。注册日期为 2017 年 3 月 13 日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5de/9641844/4a0e70ef9ef4/12877_2022_3536_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验